CO6801716A2 - GPR 119 modulators - Google Patents
GPR 119 modulatorsInfo
- Publication number
- CO6801716A2 CO6801716A2 CO13127143A CO13127143A CO6801716A2 CO 6801716 A2 CO6801716 A2 CO 6801716A2 CO 13127143 A CO13127143 A CO 13127143A CO 13127143 A CO13127143 A CO 13127143A CO 6801716 A2 CO6801716 A2 CO 6801716A2
- Authority
- CO
- Colombia
- Prior art keywords
- gpr
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41644110P | 2010-11-23 | 2010-11-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6801716A2 true CO6801716A2 (en) | 2013-11-29 |
Family
ID=45418722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO13127143A CO6801716A2 (en) | 2010-11-23 | 2013-05-23 | GPR 119 modulators |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP2643310A1 (en) |
| JP (1) | JP2013543885A (en) |
| KR (1) | KR20130083915A (en) |
| CN (1) | CN103298801A (en) |
| AP (1) | AP2013006809A0 (en) |
| AR (1) | AR088121A1 (en) |
| AU (1) | AU2011333427A1 (en) |
| BR (1) | BR112013011865A2 (en) |
| CA (1) | CA2814231A1 (en) |
| CL (1) | CL2013001054A1 (en) |
| CO (1) | CO6801716A2 (en) |
| CR (1) | CR20130139A (en) |
| CU (1) | CU20130059A7 (en) |
| DO (1) | DOP2013000102A (en) |
| EA (1) | EA201370118A1 (en) |
| EC (1) | ECSP13012630A (en) |
| GT (1) | GT201300135A (en) |
| MA (1) | MA34805B1 (en) |
| MX (1) | MX2013004083A (en) |
| NI (1) | NI201300044A (en) |
| PE (1) | PE20140409A1 (en) |
| SG (1) | SG189830A1 (en) |
| TW (1) | TWI433843B (en) |
| UY (1) | UY33742A (en) |
| WO (1) | WO2012069948A1 (en) |
| ZA (1) | ZA201302362B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA031618B1 (en) | 2011-06-09 | 2019-01-31 | Ризен Фармасьютикалз Са | Compounds as modulators of gpr-119 |
| EP2872127A1 (en) | 2012-07-11 | 2015-05-20 | Elcelyx Therapeutics, Inc. | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
| JP2017119628A (en) * | 2014-05-09 | 2017-07-06 | 日産化学工業株式会社 | Substituted azole compound and therapeutic agent for diabetes |
| CN104592120A (en) * | 2015-02-13 | 2015-05-06 | 佛山市赛维斯医药科技有限公司 | Cyclopropyl hydrazide and methoxybenzene-containing GPR119 agonist as well as preparation method and application thereof |
| CN104610151A (en) * | 2015-02-13 | 2015-05-13 | 佛山市赛维斯医药科技有限公司 | Compound containing hydrazide and alkoxy benzene structures as well as preparation method and application thereof |
| CN104892517A (en) * | 2015-02-13 | 2015-09-09 | 佛山市赛维斯医药科技有限公司 | Hydrazine compound, method for preparing same and application of hydrazine compound |
| CA3012901A1 (en) | 2016-02-18 | 2017-08-24 | Syngenta Participations Ag | Pesticidally active pyrazole derivatives |
| CN106631992B (en) * | 2017-01-05 | 2019-01-18 | 桑迪亚医药技术（上海）有限责任公司 | A kind of synthetic method of 4- oxygen -3,4- dihydro -2H- pyridine -1- t-butyl formate |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101754962B (en) * | 2007-07-19 | 2013-12-25 | 赛马拜制药公司 | N-azacyclic substituted pyrrole, imidazole, triazole and tetrazole derivatives as agonists of RUP3 or GPR119 for treatment of diabetes and metabolic disorders |
| CA2719507C (en) * | 2008-03-31 | 2018-03-27 | Metabolex, Inc. | Oxymethylene aryl compounds and uses thereof |
| CA2764021C (en) * | 2009-06-05 | 2014-04-22 | Pfizer Inc. | Gpr 119 modulators |
-
2011
- 2011-11-09 MA MA35928A patent/MA34805B1/en unknown
- 2011-11-09 JP JP2013540458A patent/JP2013543885A/en active Pending
- 2011-11-09 EP EP11802149.2A patent/EP2643310A1/en not_active Withdrawn
- 2011-11-09 PE PE2013001058A patent/PE20140409A1/en not_active Application Discontinuation
- 2011-11-09 WO PCT/IB2011/054996 patent/WO2012069948A1/en active Application Filing
- 2011-11-09 AP AP2013006809A patent/AP2013006809A0/en unknown
- 2011-11-09 CN CN2011800550665A patent/CN103298801A/en active Pending
- 2011-11-09 SG SG2013023189A patent/SG189830A1/en unknown
- 2011-11-09 CA CA2814231A patent/CA2814231A1/en not_active Abandoned
- 2011-11-09 AU AU2011333427A patent/AU2011333427A1/en not_active Abandoned
- 2011-11-09 MX MX2013004083A patent/MX2013004083A/en unknown
- 2011-11-09 EA EA201370118A patent/EA201370118A1/en unknown
- 2011-11-09 BR BR112013011865A patent/BR112013011865A2/en not_active IP Right Cessation
- 2011-11-09 KR KR1020137013064A patent/KR20130083915A/en not_active Application Discontinuation
- 2011-11-21 UY UY0001033742A patent/UY33742A/en unknown
- 2011-11-22 TW TW100142804A patent/TWI433843B/en not_active IP Right Cessation
- 2011-11-22 AR ARP110104351A patent/AR088121A1/en not_active Application Discontinuation
-
2013
- 2013-03-22 CR CR20130139A patent/CR20130139A/en unknown
- 2013-04-02 ZA ZA2013/02362A patent/ZA201302362B/en unknown
- 2013-04-16 CL CL2013001054A patent/CL2013001054A1/en unknown
- 2013-04-23 CU CU2013000059A patent/CU20130059A7/en unknown
- 2013-05-09 DO DO2013000102A patent/DOP2013000102A/en unknown
- 2013-05-13 NI NI201300044A patent/NI201300044A/en unknown
- 2013-05-20 EC ECSP13012630 patent/ECSP13012630A/en unknown
- 2013-05-21 GT GT201300135A patent/GT201300135A/en unknown
- 2013-05-23 CO CO13127143A patent/CO6801716A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NI201300044A (en) | 2013-08-01 |
| KR20130083915A (en) | 2013-07-23 |
| WO2012069948A1 (en) | 2012-05-31 |
| TW201300373A (en) | 2013-01-01 |
| CA2814231A1 (en) | 2012-05-31 |
| CR20130139A (en) | 2013-06-28 |
| BR112013011865A2 (en) | 2016-08-23 |
| TWI433843B (en) | 2014-04-11 |
| ZA201302362B (en) | 2014-06-25 |
| GT201300135A (en) | 2015-02-19 |
| CL2013001054A1 (en) | 2013-09-27 |
| EA201370118A1 (en) | 2013-12-30 |
| CU20130059A7 (en) | 2013-06-28 |
| ECSP13012630A (en) | 2013-07-31 |
| MX2013004083A (en) | 2013-06-13 |
| PE20140409A1 (en) | 2014-03-23 |
| CN103298801A (en) | 2013-09-11 |
| DOP2013000102A (en) | 2013-07-15 |
| AR088121A1 (en) | 2014-05-14 |
| EP2643310A1 (en) | 2013-10-02 |
| UY33742A (en) | 2012-06-29 |
| JP2013543885A (en) | 2013-12-09 |
| AU2011333427A1 (en) | 2013-04-11 |
| MA34805B1 (en) | 2014-01-02 |
| SG189830A1 (en) | 2013-06-28 |
| AP2013006809A0 (en) | 2013-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1014636A2 (en) | gpr modulators 119 | |
| BR112013015329A2 (en) | polyamide composition | |
| BR112013013263A2 (en) | connection set | |
| BR112013006293A2 (en) | pesticide arylpyrrolidines | |
| CO6801716A2 (en) | GPR 119 modulators | |
| BR112012018744A2 (en) | force mechanism | |
| BR112013007492A2 (en) | polypropyleterimine glycodendrimers | |
| BR112012024846A2 (en) | Hair apply | |
| ES1072740Y (en) | PAVING PART | |
| FR2963221B1 (en) | MEDAILLES DISPLAY | |
| ES1072534Y (en) | CAMPAIGN SHOP-HAMMOCK | |
| ES1072372Y (en) | ROZAS MARKER | |
| DOS2010000086S (en) | SIGN | |
| FI9030U1 (en) | Joystick | |
| UA21710S (en) | EMBLEM | |
| UA21691S (en) | EMBLEM | |
| UA21565S (en) | EMBLEM | |
| UA21323S (en) | EMBLEM | |
| UA21553S (en) | EMBLEM | |
| UA21047S (en) | EMBLEM | |
| UA21413S (en) | EMBLEM | |
| UA21366S (en) | EMBLEM | |
| UA21791S (en) | EMBLEM | |
| UA21264S (en) | EMBLEM | |
| UA21043S (en) | EMBLEM |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |